DISCLOSEDQuarterly
Bridgewater Associates
TG Therapeutics Inc · NASDAQ
429,904 sh · $23.6M
Filed 30 Jun 2026SEC 13Fview source
BlackRock
13F filer
$202.6M
11,388,346 sh
Two Sigma Investments
13F filer
$51.2M
1,542,312 sh
Bridgewater Associates
13F filer
$23.6M
429,904 sh
Renaissance Technologies
13F filer
$11.3M
340,900 sh
Polen Capital Management
13F filer
$531.5K
14,768 sh
Bridgewater Associates
TG Therapeutics Inc · NASDAQ
429,904 sh · $23.6M
Two Sigma Investments
TG Therapeutics Inc · NASDAQ
1,542,312 sh · $51.2M
Bridgewater Associates
TG Therapeutics Inc · NASDAQ
311,415 sh · $10.3M
Renaissance Technologies
TG Therapeutics Inc · NASDAQ
340,900 sh · $11.3M
Polen Capital Management
TG Therapeutics Inc · NASDAQ
14,768 sh · $531.5K
BlackRock
TG Therapeutics Inc · NASDAQ
11,388,346 sh · $202.6M